U.S. Baby Infant Formula Market By Product Type (Infant Milk, Follow-On-Milk, Specialty Milk, and Growing Up Milk), Ingredients (Carbohydrate, Fat, Protein, Minerals, Vitamins, and Others) and Distribution Channel (Hypermarket, Supermarket, Pharmacy/Medical Stores, Specialty Stores, Hard Discount Stores, and Others): Opportunity Analysis And Industry Forecast, 2021-2030
The U.S. baby infant formula market was valued at $3,889.0 million in 2020, and is projected to reach $6,784.7 million by 2030, registering a CAGR of 8.6% from 2021 to 2030.
Infant formula serves as an ideal alternative suitable for infant consumption, which mimics the nutritional composition of breast milk as closely as possible. Although physicians recommend breast milk for optimal infant nutrition, it may not always be possible, suitable, or solely adequate. Enspire infant formula and toddler milk and Similac infant formula and toddler milk are infant formulas available for healthy, full-term infants who are not breastfed or partially breastfed.
The rise in the participation of women in the labor force in the U.S. acts as a key driving force of the U.S. baby infant formula market. For instance, according to the U.S. Bureau of Statistics, the working women population increased from 57.1% in 2018 to 57.5% in 2020. Infant formula acts as an appealing alternative to working mothers for their babies as per the need and convenience. Rapid urbanization and the growth of the middle-class population have led to changes in lifestyle.
The middle-class population is more affluent and can afford to spend more on their children, thus driving market growth. In addition, consumer perception of the high nutritional content in the infant formula supplements the market growth. Furthermore, an increase in health consciousness among consumers boosts the demand for infant formula having a high content of protein, minerals, and vitamins. However, concerns related to food safety and the decline in the birth rate are anticipated to hamper the market growth. On the contrary, a shift in preference for organic infant formulas is expected to offer new avenues for manufacturers.
The U.S. baby infant formula market is segmented on the basis of product type, ingredient, distribution channel, and source. Depending on product type, the market is segregated into infant milk, follow-on milk, specialty baby milk, and growing-up milk. On the basis of ingredient, it is fragmented into carbohydrates, fat, protein, minerals, vitamins, and others. By distribution channel, it is categorized into hypermarkets, supermarkets, pharmacy/medical stores, specialty stores, hard discounter stores, and others. By source, it is classified into regular, organic, milk with HMO, goat milk, plant-based formula, and others.
The major players analyzed for the U.S. Baby Infant Formula Market are Abott Laboratories, Alra Foods Amba, Aussie Bub, Bobbie, Campbell Soups Company, Dana Dairy Group Ltd., Danone SA, D-Signstore, Else Nutrition Holdings Inc., Hipp GmbH & Co. Vertrieb KG, Holle Baby Food AG, Kabrita USA, Nature’s One, LLC, Nestle S.A, Reckitt Benckiser Group Plc, and The Hain Celestial Group, Inc.
Key benefits for the stakeholder
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook